← All organizations
Highest phase reached
Phase 2
First clinical trial
Mar 15, 2019Last known activity
Dec 31, 2025
Timeline
2010s
- Dec 1, 2016
Laekna Limited— Founded
Drugs by trial phase (9 distinct, 10 trials)
Phase 2 (7 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT07230496Lead sponsorPhase 1Dec 31, 2025
- NCT06908707Lead sponsorPhase 1Apr 22, 2025
- NCT06493084Lead sponsorPhase 1Jun 25, 2024
- NCT05489744Lead sponsorPhase 1Jul 28, 2022
- NCT05383482Lead sponsorPhase 1/Phase 2Jun 30, 2022
- NCT04851613Lead sponsorPhase 1Sep 30, 2021
- NCT05390710Lead sponsorPhase 1/Phase 2Jun 12, 2021
- NCT04374630Lead sponsorPhase 2Jun 9, 2020
- NCT04060394Lead sponsorPhase 1/Phase 2Aug 31, 2019
- NCT04060394Study chairPhase 1/Phase 2Aug 31, 2019
- NCT03843918Lead sponsorPhase 1/Phase 2Mar 15, 2019
Details
- Founded
- Shanghai, CN Dec 1, 2016
- Last known activity
- Dec 31, 2025